These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8610959)

  • 21. Nonalcoholic steatohepatitis (NASH): further expansion of this clinical entity?
    Brunt EM
    Liver; 1999 Aug; 19(4):263-4. PubMed ID: 10459622
    [No Abstract]   [Full Text] [Related]  

  • 22. Invasive and non-invasive investigations for tamoxifen-induced non-alcoholic steatohepatitis (NASH): the benefit of computed tomography scan guided liver biopsy.
    Ahmed MH; Osman KA; Osman MM
    Pathology; 2006 Jun; 38(3):270-1. PubMed ID: 16753757
    [No Abstract]   [Full Text] [Related]  

  • 23. Incidence and risk factors for non-alcoholic steatohepatitis in females treated with tamoxifen for breast cancer.
    Akhondi-Meybodi M; Mortazavy-Zadah MR; Hashemian Z; Moaiedi M
    Arab J Gastroenterol; 2011 Mar; 12(1):34-6. PubMed ID: 21429453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allopurinol hepatotoxicity potentiated by tamoxifen.
    Shah KA; Levin J; Rosen N; Greenwald E; Zumoff B
    N Y State J Med; 1982 Nov; 82(12):1745-6. PubMed ID: 6960280
    [No Abstract]   [Full Text] [Related]  

  • 25. Tamoxifen-induced submassive hepatic necrosis.
    Storen EC; Hay JE; Kaur J; Zahasky K; Hartmann L
    Cancer J; 2000; 6(2):58-60. PubMed ID: 11069218
    [No Abstract]   [Full Text] [Related]  

  • 26. Subacute severe steatohepatitis during prednisolone therapy for systemic lupus erythematosis.
    Nanki T; Koike R; Miyasaka N
    Am J Gastroenterol; 1999 Nov; 94(11):3379. PubMed ID: 10566758
    [No Abstract]   [Full Text] [Related]  

  • 27. Drug-induced steatohepatitis leading to cirrhosis: long-term toxicity of amiodarone use.
    Raja K; Thung SN; Fiel MI; Chang C
    Semin Liver Dis; 2009 Nov; 29(4):423-8. PubMed ID: 19826976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tamoxifen-induced fatty liver in patients with breast cancer.
    Ogawa Y; Murata Y; Nishioka A; Inomata T; Yoshida S
    Lancet; 1998 Mar; 351(9104):725. PubMed ID: 9504521
    [No Abstract]   [Full Text] [Related]  

  • 29. [Drug-induced NASH].
    Saibara T; Onishi S
    Nihon Rinsho; 2006 Jun; 64(6):1100-5. PubMed ID: 16768116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Viral Hepatitis A over imposed on chronic hepatic damage due to tamoxifen: report of a case].
    Vildozola H; Vargas G; Takano J
    Rev Gastroenterol Peru; 2007; 27(1):67-71. PubMed ID: 17431437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hepatitis during treatment with tamoxifen. Effects on the kinetics of epirubicin].
    Bressollette L; Swirsky H; Kernaleguen D; Carlhant D; Fauquert P; Le Bot MA; Baccino E; Riche C
    Therapie; 1989; 44(2):151-2. PubMed ID: 2756522
    [No Abstract]   [Full Text] [Related]  

  • 32. Tamoxifen-induced hepatotoxicity.
    Ahbeddou N; Belbaraka R; Fetohi M; Errihani H
    Indian J Cancer; 2011; 48(3):385. PubMed ID: 21921356
    [No Abstract]   [Full Text] [Related]  

  • 33. Fatty change.
    Thaler H
    Baillieres Clin Gastroenterol; 1988 Apr; 2(2):453-62. PubMed ID: 3044470
    [No Abstract]   [Full Text] [Related]  

  • 34. Tamoxifen-induced nonalcoholic steatohepatitis in breast cancer patients treated with adjuvant tamoxifen.
    Nemoto Y; Saibara T; Ogawa Y; Zhang T; Xu N; Ono M; Akisawa N; Iwasaki S; Maeda T; Onishi S
    Intern Med; 2002 May; 41(5):345-50. PubMed ID: 12058881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A new drug responsible for microvesicular steatosis: ticlopidine].
    Remy AJ; Heran B; Galindo G; Tapie C; Khemissa F; Larrey D
    Gastroenterol Clin Biol; 1999 Jan; 23(1):151-2. PubMed ID: 10219621
    [No Abstract]   [Full Text] [Related]  

  • 36. [Liver necrosis in consequence of fluothane anesthesia].
    Mihalecz K; Császár J
    Zentralbl Chir; 1967 Sep; 92(38):2585-8. PubMed ID: 5595515
    [No Abstract]   [Full Text] [Related]  

  • 37. [Chronic drug-induced hepatopathies. Imputability and clinical aspects].
    Valla D
    Gastroenterol Clin Biol; 1995; 19(5 Pt 2):B63-6. PubMed ID: 8522104
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hepatotoxic effect of antineoplastic drugs].
    Robak T; Matusewicz W
    Pol Tyg Lek; 1984 Apr; 39(14):479-83. PubMed ID: 6382218
    [No Abstract]   [Full Text] [Related]  

  • 39. Iatrogenic hyperadrenocorticism and steatohepatitis caused by unapproved medicine.
    Kitahara A; Saga K; Koide S; Isobe T; Oki Y; Nakamura H
    Intern Med; 2008; 47(13):1231-6. PubMed ID: 18591846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Drug-induced steatosis, phospholipidosis and pseudo-alcoholic liver disorders].
    Fréneaux E; Pessayre D
    Gastroenterol Clin Biol; 1993; 17(5 Pt 2):H36-43. PubMed ID: 8243916
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.